Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 271-808-0 | CAS number: 68608-89-9 This substance is identified by SDA Substance Name: C11-C13 branched alkyl benzene sulfonic acid sodium salt and SDA Reporting Number: 25-097-04.
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Tests were conducted to compare the acute toxicity oral of BABS Na salt versus LAS. Results indicate they are comparable, supporting the use of LAS as an analogue. BABS Na salt oral LD50=520 mg/kg bw; dermal LD50=1000 mg/kg bw.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Well documented journal article.
- Qualifier:
- according to guideline
- Guideline:
- other: Hagan, EC (1959). Acute toxicity. In: Appraisal of the Safety of Chemicals in Foods, Drugs and Cosmetics. pp. 17-25. Assoc. of Food and Drug Officials of the US, Bureau of Food and Drugs, Texas State Dept. of Health, Austin, Texas.
- GLP compliance:
- no
- Remarks:
- Study performed in 1965 prior to implementation of GLP.
- Limit test:
- no
- Species:
- rat
- Strain:
- other: FDRL
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Age at study initiation: young adult
- Fasting period before study: overnight - Route of administration:
- oral: gavage
- Vehicle:
- water
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle: 10% dispersion in water, LAS was also given in a 40% dispersion
- Purity: distilled water - Doses:
- graded doses
LAS: 0.6, 1.58 g/kg - No. of animals per sex per dose:
- 3 rats of each sex per dose
- Control animals:
- yes
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: observations for behaviour, appearance and survival were made daily; weighings were performed on days 0, 7, and 14
- Necropsy of survivors performed: yes - Statistics:
- LD50 calculated by the method of Miller, LC, and Tainter, ML. (1994). Estimation of the ED50 and its error by means of logarithmic-probit graph paper. Proc. Soc. Exptl. Biol. Med. 57, 261-264.
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- 0.52 other: g/kg
- Based on:
- act. ingr.
- 95% CL:
- 0.424 - 0.614
- Remarks on result:
- other: BABS Na salt
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- 0.65 other: g/kg
- Based on:
- act. ingr.
- 95% CL:
- 0.587 - 0.713
- Remarks on result:
- other: LAS
- Mortality:
- No effects.
- Clinical signs:
- other: At the high LAS dose, a high incidence of diarrhea was noted. Animals that died during the study showed weakness and reduced activity prior to death.
- Gross pathology:
- No effects.
- Interpretation of results:
- Category 4 based on GHS criteria
- Remarks:
- Migrated information
- Conclusions:
- The acute oral LD50 for BABS Na salt in rats is 520 mg/kg bw. This places BABS Na salt in toxicity category 4.
- Executive summary:
Groups of 3 male and 3 female rats were administered various doses of BABS Na salt or LAS. The animals were oberseved for 14 days for survival, behaviour, and appearance. In addition, body weights were taken on days 0, 7, and 14. The LD50 for BABS Na salt was 520 mg/kg, and the LD50 for LAS was 650 mg/kg. The LD50s for LAS and BABS Na salt were not statistically different. This demonstrates that LAS is a suitable analog for BABS Na salt regarding toxicity.
Reference
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 520 mg/kg bw
- Quality of whole database:
- The single available study has a reliability rating of 2.
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- migrated information: read-across based on grouping of substances (category approach)
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP laboratory study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 402 (Acute Dermal Toxicity)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- standard acute method
- Limit test:
- no
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Hoechst AG, Kastengrund, SPF breeding colony
- Age at study initiation: males, approx. 7 weeks; females, approx. 8 weeks
- Weight at study initiation: males, mean = 197 g; females, mean = 193 g
- Fasting period before study: yes
- Housing: Makrolon Type 4 cages on soft wood granulate in groups of 5 animals in fully air-conditioned rooms
- Diet (e.g. ad libitum): ad libitum, Atlromin 1324 rat diet
- Water (e.g. ad libitum): ad libitum, tap water in plastic bottles
- Acclimation period: Not necessary
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 +/- 3 C
- Humidity (%): 55 +/- 20%
- Air changes (per hr): Not stated
- Photoperiod (hrs dark / hrs light): 12:12 dark:light - Type of coverage:
- occlusive
- Vehicle:
- other: sesame oil
- Details on dermal exposure:
- TEST SITE
- Area of exposure: 30 cm2
- Type of wrap if used: aluminum foil held in place with an elastic plaster bandage
REMOVAL OF TEST SUBSTANCE
- Washing (if done): washed with warm water
- Time after start of exposure: 24 hours
TEST MATERIAL
- Amount(s) applied (volume or weight with unit): 4 mL/kg bw
- Concentration (if solution): 25, 40 and 50% for doses 1000, 1600 and 2000 mg/kg bw, respectively
- Constant volume or concentration used: yes - Duration of exposure:
- 24 hours
- Doses:
- 1000, 1600, and 2000 mg/kg bw
- No. of animals per sex per dose:
- 5 males for each of the 1000 and 1600 mg/kg bw doses; 5 males and 5 females for the 2000 mg/kg bw dose
- Control animals:
- not specified
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: Symptoms and lethality recorded twice per day (morning and afternoon) on weekdays and once daily on weekends and holidays. Animals found dead were dissected as soon as possible and examined fro macroscopically visible changes. During the observation period the animals were weighed weekly.
- Necropsy of survivors performed: yes. Surviving animals were sacrificed at the end of the observation period, dissected, and examined for macroscopically visible changes. - Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 1 000 - < 1 600 mg/kg bw
- Based on:
- test mat.
- Mortality:
- Mortality was observed at doses of 1600 and 2000 mg/kg bw, but not at 1000 mg/kg bw (see table). Lethality was noted only up to day three of the study.
- Clinical signs:
- other: Besides unspecific symptoms, the animals showed impairments of respiration, motility and reflexes. They also exhibited stupor, prone position, trembling, hypothermia, narrowed palpebral fissures, and blood-encrusted snouts. These symptoms disappeared in
- Gross pathology:
- At necropsy, blood in the intestinal tract and diffuse reddening of the stomach mucosa were observed in animals found dead. Light or dark discolorations of the liver occurred in two dead male animals of the 2000 mg/kg bw group. No macroscopically visible changes were observed in surviving animals that were sacrificed at the end of the observation period.
- Interpretation of results:
- Toxicity Category IV
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- The acute dermal LD50 of phenylsulfonat CA is between 1000 and 1600 mg/kg bw.
- Executive summary:
The acute dermal toxicity of Branched CaDDBS (Phenylsulfonat CA) was tested in male and female Wistar rats at doses of 1000, 1600 and 2000 mg/kg bw. Lethality was observed in the 1600 and 2000 mg/kg bw doses but not in the 1000 mg/kg bw dose. All lethality had occurred by day three of the post application observation period. Other signs of toxicity included impairments of respiration, motility and reflexes, as well as stupor, prone position, trembling, hypothermia, narrowed palpebral fissures, and blood-encrusted snouts, all of which had disappeared by eight days post application. The skin showed erythema, fine and coarse scales, desquamations and scars, as well as discoloration, induration, chapping, scabbing and lumpiness. No effects on body weight gain were observed. The resultant acute dermal LD50 is >1000 and <1600 mg/kg bw.
Reference
Dose mg/kg bw |
Lethality |
|||
Male |
Female |
|||
Number |
Percent |
Number |
Percent |
|
1000 |
0/5 |
0 |
- |
- |
1600 |
5/5 |
100 |
- |
- |
2000 |
4/5 |
80 |
3/5 |
60 |
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 1 000 mg/kg bw
Additional information
The endpoint records reflect data from BABS Na salt where available. In cases where data is not available, data on analogues substances are used. The analogue substances used included: 1) the sodium salt of linear alkylbenzene sulfonate (commonly known as LAS or Na-LAS); and 2) the calcium salt of branched alkylbenzene sulfonate (commonly known as Branched CaDDBS). LAS is the sodium salt of linear alkylbenzene sulfonic acid with alkyl carbon chain lengths ranging from C10 to C13 and averaging 11.6. The primary structure is a C10 to C13 linear alkyl chain with a para-substituted benzene sulfonic acid sodium salt group attached at any of the secondary alkyl carbon positions. Branched CaDDBS is the calcium salt of branched alkylbenzene sulfonic acid with alkyl chain lengths ranging from C11 to C13. The primary difference between LAS and BABS Na salt is the alkyl chain, branched vs. linear. The primary difference between Branched CaDDBS and BABS Na salt is the salt, calcium vs. sodium. Given their structural and functional similarities, LAS and Branched CaDDBS are good analogues for read-across for instances where data are available on them but not on BABS Na salt. When studies on both analogues are available, all data are provided and the most conservative (most health protective) data is used for classification and labeling.
Tests were conducted to compare the acute oral toxicity of BABS Na salt and LAS. Groups of 3 male and 3 female rats were administered various doses of BABS Na salt or LAS. The animals were observed for 14 days for survival, behaviour, and appearance. In addition, body weights were taken on days 0, 7, and 14. The LD50 for BABS Na salt was 520 mg/kg, and the LD50 for LAS was 650 mg/kg. The LD50s for LAS and BABS Na salt were not statistically different. This demonstrates that LAS is a suitable analog for BABS Na salt regarding toxicity.
Based on read across from studies with Branched CaDDBS and LAS, the dermal LD50 for BABS Na salt is LD50 = > 1000 - <1600 mg/kg.
Justification for selection of acute toxicity – oral endpoint
The selected oral toxicity study is the only acute toxicity study available for BABS Na salt.
Justification for classification or non-classification
BABS Na salt is classified as Category 4 for both oral and dermal toxicity under the CLP regulation for oral (LD50 = 520 mg/kg) and dermal (LD50 = > 1000 - < 1600 mg/kg) toxicity; DSD classification is R21/R22, harmful in contact with skin and harmful if swallowed.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.